Dupilumab for adolescents with moderate-to-severe atopic dermatitis: Results from a phase 3, randomized, double-blinded trial Meeting Abstract

publication date

  • October 1, 2019

webpage

published in

start page

  • AB195

end page

  • AB195

volume

  • 81

issue

  • 4